We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAF
3751
abrdn Australia Equity Fund
IAF
$122M
$126K ﹤0.01%
8,941
-350
-4% -$4.67K
FTCI icon
3752
FTC Solar
FTCI
$43.2M
$126K ﹤0.01%
18,540
-920
-5% -$3.32K
OPBK icon
3753
OP Bancorp
OPBK
$241M
$126K ﹤0.01%
10,078
FSM icon
3754
Fortuna Silver Mines
FSM
$2.55B
$124K ﹤0.01%
26,791
+1,988
+8% +$9.43K
ICMB icon
3755
Investcorp Credit Management BDC
ICMB
$11M
$124K ﹤0.01%
39,492
+300
+0.8% +$973
PAGS icon
3756
PagSeguro Digital
PAGS
$2.69B
$123K ﹤0.01%
14,305
-61,466
-81% -$711K
XERS icon
3757
Xeris Biopharma Holdings
XERS
$1.42B
$120K ﹤0.01%
+42,062
New +$108K
SJT
3758
San Juan Basin Royalty Trust
SJT
$117M
$120K ﹤0.01%
32,341
-382
-1% -$1.43K
GLO
3759
Clough Global Opportunities Fund
GLO
$246M
$117K ﹤0.01%
21,501
-2,245
-9% -$12K
ORLA
3760
Orla Mining
ORLA
$3.42B
$117K ﹤0.01%
29,191
+3,775
+15% +$15K
ESRT icon
3761
Empire State Realty Trust
ESRT
$976M
$116K ﹤0.01%
+10,486
New +$109K
SWIM icon
3762
Latham Group
SWIM
$673M
$115K ﹤0.01%
+16,985
New +$82.6K
EPD icon
3763
PUT
Enterprise Products Partners
EPD
$83.6B
$115K ﹤0.01%
5,000
CDMO
3764
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$115K ﹤0.01%
10,100
IBRX icon
3765
ImmunityBio
IBRX
$7.3B
$114K ﹤0.01%
30,613
+2,000
+7% +$9.26K
HLX icon
3766
Helix Energy Solutions
HLX
$1.35B
$113K ﹤0.01%
+10,165
New +$112K
DVAX
3767
DELISTED
Dynavax Technologies
DVAX
$113K ﹤0.01%
+10,125
New +$112K
AUPH icon
3768
Aurinia Pharmaceuticals
AUPH
$1.92B
$112K ﹤0.01%
15,225
-475
-3% -$2.94K
FCT
3769
First Trust Senior Floating Rate Income Fund II
FCT
$251M
$111K ﹤0.01%
10,757
-2,544
-19% -$26.1K
PHM icon
3770
PUT
Pultegroup
PHM
$25.7B
$110K ﹤0.01%
+1,000
New +$127K
RPT
3771
Rithm Property Trust
RPT
$95.8M
$109K ﹤0.01%
5,436
-1,160
-18% -$24.1K
FINV
3772
FinVolution Group
FINV
$1.16B
$107K ﹤0.01%
17,376
OPFI icon
3773
OppFi
OPFI
$824M
$107K ﹤0.01%
22,626
+200
+0.9% +$830
ACCD
3774
DELISTED
Accolade Inc
ACCD
$104K ﹤0.01%
26,970
+778
+3% +$3.05K
PR
3775
CALL
Permian Resources
PR
$16.5B
$103K ﹤0.01%
10,300

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.